发明名称 |
PURIFIED EMD PROTEIN COMPOSITION |
摘要 |
The present invention relates to an improved pharmaceutical, dental and/or cosmetic composition consisting of purified Enamel Matrix Derivative (EMD) proteins which have a molecular weight between 1 and 55kDa, formulated in a suitable pharmaceutical carrier. The present invention further relates to an improved pharmaceutical, dental and/or cosmetic composition comprising purified Enamel Matrix Derivative (EMD) proteins, which is depleted of proteins which have a molecular weight between 56 and 160kDa and an iso-electric point between 3-10. The improved pharmaceutical, dental and/or cosmetic composition of the present invention comprises purified Enamel Matrix Derivative (EMD) proteins, which are depleted of proteinase inhibitors, such as a1-antichymotrypsin and/or Fetuin A. Said improved composition is herein preferably intended to be used for promoting and/or inducing regeneration of hard tissue, tissue mineralization, bone growth and/or bone regrowth, regeneration of dentin, cementogenesis, and/or binding between parts of living mineralized tissue, for bonding of a piece of living mineralized tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma. |
申请公布号 |
WO2011051457(A3) |
申请公布日期 |
2012.02.16 |
申请号 |
WO2010EP66486 |
申请日期 |
2010.10.29 |
申请人 |
STRAUMANN HOLDING AG;BARTHOLD, MARK, P.;ZILM, PETER, S.;MAUTH, CORINNA;RANEVSKI, RUZICA |
发明人 |
BARTHOLD, MARK, P.;ZILM, PETER, S.;MAUTH, CORINNA;RANEVSKI, RUZICA |
分类号 |
A61L15/32;A61K6/00;A61K8/19;A61K8/64;A61K8/98;A61K38/17;A61K38/39;A61L24/10;A61L26/00;A61L27/00;A61L27/22;A61L27/36;A61Q11/00;A61Q17/00;A61Q19/00 |
主分类号 |
A61L15/32 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|